Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems
Driven by the concept of plug-and-play cell culture-based viral vaccine production using disposable bioreactors, we evaluated an orbital shaken bioreactor (OSB) for human influenza A virus production at high cell concentration. Therefore, the OSB model SB10-X was coupled to two hollow fiber-based pe...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2019-11, Vol.37 (47), p.7011-7018 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7018 |
|---|---|
| container_issue | 47 |
| container_start_page | 7011 |
| container_title | Vaccine |
| container_volume | 37 |
| creator | Coronel, Juliana Behrendt, Ilona Bürgin, Tim Anderlei, Tibor Sandig, Volker Reichl, Udo Genzel, Yvonne |
| description | Driven by the concept of plug-and-play cell culture-based viral vaccine production using disposable bioreactors, we evaluated an orbital shaken bioreactor (OSB) for human influenza A virus production at high cell concentration. Therefore, the OSB model SB10-X was coupled to two hollow fiber-based perfusion systems, namely, tangential flow filtration (TFF) and alternating tangential flow filtration (ATF). The AGE1.CR.pIX avian suspension cells grew to 50 × 106 cells/mL in chemically defined medium, maintaining high cell viabilities with an average specific growth rate of 0.020 h−1 (doubling time = 32 h). Maximum virus titers in the range of 3.28–3.73 log10(HA units/100 µL) were achieved, corresponding to cell-specific virus yields of 1000–3500 virions/cell and productivities of 0.5–2.2 × 1012 virions/L/d. This clearly demonstrates the potential of OSB operation in perfusion mode, as results achieved in a reference OSB batch cultivation were 2.64 log10(HA units/100 µL), 1286 virions/cell and 1.4 × 1012 virions/L/d, respectively. In summary, the SB10-X bioreactor can be operated with ATF and TFF systems, which is to our knowledge the first report regarding OSB operation in perfusion mode. Moreover, the results showed that the system is a promising cultivation system for influenza A virus vaccine production. The OSB disposable bioreactor has the potential for simplifying the scale-up from shake flasks to the large-scale bioreactor, facilitating rapid responses in the event of epidemics or pandemics. |
| doi_str_mv | 10.1016/j.vaccine.2019.06.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2251691606</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X19307649</els_id><sourcerecordid>2251691606</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-9fedec4bdf338188ad8e19fa7229774acaeccc52f2ee40a7df0bf8873ce96f4a3</originalsourceid><addsrcrecordid>eNqFkTFv2zAQhYmiQeO4_QkNCHTJIoWkaEqaAiOI0wABsjhAN4KijjVdmXRI0UX660PBbocsveWW797dvYfQV0pKSqi43pYHpbV1UDJC25KIkpDFBzSjTV0VbEGbj2hGmOAFp-THObqIcUsyUdH2EzqvKBO52hnaPDgzJHB_FF7igw0p4n3wfdKj9Q5bhxWO1v0coEgRsA-dHdWA40b9Aoc76wMoPfqAf9txg5frVUbwerXCewgmxUkjvsYRdvEzOjNqiPDl1OfoeXW3vv1ePD7dP9wuHwvNORmL1kAPmne9qaqGNo3qG6CtUTVjbV1zpRVorRfMMABOVN0b0pkm_6yhFYarao6ujrr5jZcEcZQ7GzUMg3LgU5QseyNaKojI6Ld36Nan4PJ1klWUsJrxaqIWR0oHH2MAI_fB7lR4lZTIKQq5laco5BSFJEJORs_R5Uk9dTvo_0399T4DN0cAsh0HC0FGbcFp6G0APcre2_-seAO8454l</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2310272436</pqid></control><display><type>article</type><title>Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems</title><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central</source><creator>Coronel, Juliana ; Behrendt, Ilona ; Bürgin, Tim ; Anderlei, Tibor ; Sandig, Volker ; Reichl, Udo ; Genzel, Yvonne</creator><creatorcontrib>Coronel, Juliana ; Behrendt, Ilona ; Bürgin, Tim ; Anderlei, Tibor ; Sandig, Volker ; Reichl, Udo ; Genzel, Yvonne</creatorcontrib><description>Driven by the concept of plug-and-play cell culture-based viral vaccine production using disposable bioreactors, we evaluated an orbital shaken bioreactor (OSB) for human influenza A virus production at high cell concentration. Therefore, the OSB model SB10-X was coupled to two hollow fiber-based perfusion systems, namely, tangential flow filtration (TFF) and alternating tangential flow filtration (ATF). The AGE1.CR.pIX avian suspension cells grew to 50 × 106 cells/mL in chemically defined medium, maintaining high cell viabilities with an average specific growth rate of 0.020 h−1 (doubling time = 32 h). Maximum virus titers in the range of 3.28–3.73 log10(HA units/100 µL) were achieved, corresponding to cell-specific virus yields of 1000–3500 virions/cell and productivities of 0.5–2.2 × 1012 virions/L/d. This clearly demonstrates the potential of OSB operation in perfusion mode, as results achieved in a reference OSB batch cultivation were 2.64 log10(HA units/100 µL), 1286 virions/cell and 1.4 × 1012 virions/L/d, respectively. In summary, the SB10-X bioreactor can be operated with ATF and TFF systems, which is to our knowledge the first report regarding OSB operation in perfusion mode. Moreover, the results showed that the system is a promising cultivation system for influenza A virus vaccine production. The OSB disposable bioreactor has the potential for simplifying the scale-up from shake flasks to the large-scale bioreactor, facilitating rapid responses in the event of epidemics or pandemics.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2019.06.005</identifier><identifier>PMID: 31266669</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Bioreactors ; Cell culture ; Cell growth ; Cultivation ; Epidemics ; Filtration ; Flasks ; Growth rate ; High cell density ; Hollow-fiber ; Immunization ; Influenza ; Influenza A ; Influenza A virus ; Manufacturing ; Orbital shaken bioreactor ; Organic chemistry ; Pandemics ; Perfusion ; Propagation ; Shear stress ; Vaccines ; Viral vaccine production ; Virions ; Viruses</subject><ispartof>Vaccine, 2019-11, Vol.37 (47), p.7011-7018</ispartof><rights>2019 The Authors</rights><rights>Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><rights>2019. The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-9fedec4bdf338188ad8e19fa7229774acaeccc52f2ee40a7df0bf8873ce96f4a3</citedby><cites>FETCH-LOGICAL-c440t-9fedec4bdf338188ad8e19fa7229774acaeccc52f2ee40a7df0bf8873ce96f4a3</cites><orcidid>0000-0002-2652-5943 ; 0000-0002-1349-2310</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2310272436?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31266669$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Coronel, Juliana</creatorcontrib><creatorcontrib>Behrendt, Ilona</creatorcontrib><creatorcontrib>Bürgin, Tim</creatorcontrib><creatorcontrib>Anderlei, Tibor</creatorcontrib><creatorcontrib>Sandig, Volker</creatorcontrib><creatorcontrib>Reichl, Udo</creatorcontrib><creatorcontrib>Genzel, Yvonne</creatorcontrib><title>Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Driven by the concept of plug-and-play cell culture-based viral vaccine production using disposable bioreactors, we evaluated an orbital shaken bioreactor (OSB) for human influenza A virus production at high cell concentration. Therefore, the OSB model SB10-X was coupled to two hollow fiber-based perfusion systems, namely, tangential flow filtration (TFF) and alternating tangential flow filtration (ATF). The AGE1.CR.pIX avian suspension cells grew to 50 × 106 cells/mL in chemically defined medium, maintaining high cell viabilities with an average specific growth rate of 0.020 h−1 (doubling time = 32 h). Maximum virus titers in the range of 3.28–3.73 log10(HA units/100 µL) were achieved, corresponding to cell-specific virus yields of 1000–3500 virions/cell and productivities of 0.5–2.2 × 1012 virions/L/d. This clearly demonstrates the potential of OSB operation in perfusion mode, as results achieved in a reference OSB batch cultivation were 2.64 log10(HA units/100 µL), 1286 virions/cell and 1.4 × 1012 virions/L/d, respectively. In summary, the SB10-X bioreactor can be operated with ATF and TFF systems, which is to our knowledge the first report regarding OSB operation in perfusion mode. Moreover, the results showed that the system is a promising cultivation system for influenza A virus vaccine production. The OSB disposable bioreactor has the potential for simplifying the scale-up from shake flasks to the large-scale bioreactor, facilitating rapid responses in the event of epidemics or pandemics.</description><subject>Bioreactors</subject><subject>Cell culture</subject><subject>Cell growth</subject><subject>Cultivation</subject><subject>Epidemics</subject><subject>Filtration</subject><subject>Flasks</subject><subject>Growth rate</subject><subject>High cell density</subject><subject>Hollow-fiber</subject><subject>Immunization</subject><subject>Influenza</subject><subject>Influenza A</subject><subject>Influenza A virus</subject><subject>Manufacturing</subject><subject>Orbital shaken bioreactor</subject><subject>Organic chemistry</subject><subject>Pandemics</subject><subject>Perfusion</subject><subject>Propagation</subject><subject>Shear stress</subject><subject>Vaccines</subject><subject>Viral vaccine production</subject><subject>Virions</subject><subject>Viruses</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkTFv2zAQhYmiQeO4_QkNCHTJIoWkaEqaAiOI0wABsjhAN4KijjVdmXRI0UX660PBbocsveWW797dvYfQV0pKSqi43pYHpbV1UDJC25KIkpDFBzSjTV0VbEGbj2hGmOAFp-THObqIcUsyUdH2EzqvKBO52hnaPDgzJHB_FF7igw0p4n3wfdKj9Q5bhxWO1v0coEgRsA-dHdWA40b9Aoc76wMoPfqAf9txg5frVUbwerXCewgmxUkjvsYRdvEzOjNqiPDl1OfoeXW3vv1ePD7dP9wuHwvNORmL1kAPmne9qaqGNo3qG6CtUTVjbV1zpRVorRfMMABOVN0b0pkm_6yhFYarao6ujrr5jZcEcZQ7GzUMg3LgU5QseyNaKojI6Ld36Nan4PJ1klWUsJrxaqIWR0oHH2MAI_fB7lR4lZTIKQq5laco5BSFJEJORs_R5Uk9dTvo_0399T4DN0cAsh0HC0FGbcFp6G0APcre2_-seAO8454l</recordid><startdate>20191108</startdate><enddate>20191108</enddate><creator>Coronel, Juliana</creator><creator>Behrendt, Ilona</creator><creator>Bürgin, Tim</creator><creator>Anderlei, Tibor</creator><creator>Sandig, Volker</creator><creator>Reichl, Udo</creator><creator>Genzel, Yvonne</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2652-5943</orcidid><orcidid>https://orcid.org/0000-0002-1349-2310</orcidid></search><sort><creationdate>20191108</creationdate><title>Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems</title><author>Coronel, Juliana ; Behrendt, Ilona ; Bürgin, Tim ; Anderlei, Tibor ; Sandig, Volker ; Reichl, Udo ; Genzel, Yvonne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-9fedec4bdf338188ad8e19fa7229774acaeccc52f2ee40a7df0bf8873ce96f4a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Bioreactors</topic><topic>Cell culture</topic><topic>Cell growth</topic><topic>Cultivation</topic><topic>Epidemics</topic><topic>Filtration</topic><topic>Flasks</topic><topic>Growth rate</topic><topic>High cell density</topic><topic>Hollow-fiber</topic><topic>Immunization</topic><topic>Influenza</topic><topic>Influenza A</topic><topic>Influenza A virus</topic><topic>Manufacturing</topic><topic>Orbital shaken bioreactor</topic><topic>Organic chemistry</topic><topic>Pandemics</topic><topic>Perfusion</topic><topic>Propagation</topic><topic>Shear stress</topic><topic>Vaccines</topic><topic>Viral vaccine production</topic><topic>Virions</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coronel, Juliana</creatorcontrib><creatorcontrib>Behrendt, Ilona</creatorcontrib><creatorcontrib>Bürgin, Tim</creatorcontrib><creatorcontrib>Anderlei, Tibor</creatorcontrib><creatorcontrib>Sandig, Volker</creatorcontrib><creatorcontrib>Reichl, Udo</creatorcontrib><creatorcontrib>Genzel, Yvonne</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Family Health Database (Proquest)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coronel, Juliana</au><au>Behrendt, Ilona</au><au>Bürgin, Tim</au><au>Anderlei, Tibor</au><au>Sandig, Volker</au><au>Reichl, Udo</au><au>Genzel, Yvonne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2019-11-08</date><risdate>2019</risdate><volume>37</volume><issue>47</issue><spage>7011</spage><epage>7018</epage><pages>7011-7018</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Driven by the concept of plug-and-play cell culture-based viral vaccine production using disposable bioreactors, we evaluated an orbital shaken bioreactor (OSB) for human influenza A virus production at high cell concentration. Therefore, the OSB model SB10-X was coupled to two hollow fiber-based perfusion systems, namely, tangential flow filtration (TFF) and alternating tangential flow filtration (ATF). The AGE1.CR.pIX avian suspension cells grew to 50 × 106 cells/mL in chemically defined medium, maintaining high cell viabilities with an average specific growth rate of 0.020 h−1 (doubling time = 32 h). Maximum virus titers in the range of 3.28–3.73 log10(HA units/100 µL) were achieved, corresponding to cell-specific virus yields of 1000–3500 virions/cell and productivities of 0.5–2.2 × 1012 virions/L/d. This clearly demonstrates the potential of OSB operation in perfusion mode, as results achieved in a reference OSB batch cultivation were 2.64 log10(HA units/100 µL), 1286 virions/cell and 1.4 × 1012 virions/L/d, respectively. In summary, the SB10-X bioreactor can be operated with ATF and TFF systems, which is to our knowledge the first report regarding OSB operation in perfusion mode. Moreover, the results showed that the system is a promising cultivation system for influenza A virus vaccine production. The OSB disposable bioreactor has the potential for simplifying the scale-up from shake flasks to the large-scale bioreactor, facilitating rapid responses in the event of epidemics or pandemics.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>31266669</pmid><doi>10.1016/j.vaccine.2019.06.005</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-2652-5943</orcidid><orcidid>https://orcid.org/0000-0002-1349-2310</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2019-11, Vol.37 (47), p.7011-7018 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2251691606 |
| source | Access via ScienceDirect (Elsevier); ProQuest Central |
| subjects | Bioreactors Cell culture Cell growth Cultivation Epidemics Filtration Flasks Growth rate High cell density Hollow-fiber Immunization Influenza Influenza A Influenza A virus Manufacturing Orbital shaken bioreactor Organic chemistry Pandemics Perfusion Propagation Shear stress Vaccines Viral vaccine production Virions Viruses |
| title | Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A05%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influenza%20A%20virus%20production%20in%20a%20single-use%20orbital%20shaken%20bioreactor%20with%20ATF%20or%20TFF%20perfusion%20systems&rft.jtitle=Vaccine&rft.au=Coronel,%20Juliana&rft.date=2019-11-08&rft.volume=37&rft.issue=47&rft.spage=7011&rft.epage=7018&rft.pages=7011-7018&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2019.06.005&rft_dat=%3Cproquest_cross%3E2251691606%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2310272436&rft_id=info:pmid/31266669&rft_els_id=S0264410X19307649&rfr_iscdi=true |